The Transferrin Receptor-Directed CAR for the Therapy of Hematologic Malignancies

As many patients ultimately relapse after chimeric antigen receptor (CAR) T-cell therapy, identification of alternative targets is currently being evaluated. Substantial research efforts are underway to develop new targets. The transferrin receptor (TfR) is prevalently expressed on rapidly prolifera...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Front Immunol
Asıl Yazarlar: Guo, Zilong, Zhang, Yirui, Fu, Mingpeng, Zhao, Liang, Wang, Zhen, Xu, Zhuoshuo, Zhu, Huifen, Lan, Xiaoli, Shen, Guanxin, He, Yong, Lei, Ping
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Frontiers Media S.A. 2021
Konular:
Immunology
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8039461/
https://ncbi.nlm.nih.gov/pubmed/33854512
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fimmu.2021.652924
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller